Mylan Inc. Pulls EU Application for Generic Taxotere
Published: Mar 15, 2010
Reuters -- Mylan (MYL.O) has withdrawn its application to market a generic version of Sanofi-Aventis's (SASY.PA) cancer drug in Europe, after adverse feedback from regulators.